Literature DB >> 29529529

The putative interplay between DJ-1/NRF2 and Dimethyl Fumarate: A potentially important pharmacological target.

George Vavougios1, Sotirios G Zarogiannis2, Triantafylos Doskas3.   

Abstract

Recent research has outlined that Dimethyl Fumarate (DMF) functions as a gene regulator via multiple pathways, critical among which is the NRF2 cytoprotective cascade. PARK7/DJ-1 is a multifunctional protein that acts as a redox sensor and effector of multiple cytoprotective pathways, including NRF2. Specifically, it prevents the association of NRF2 with its inhibitor KEAP1, allowing NRF2 to enter the nucleus and mediate cytoprotective and antioxidant cascades. It is our hypothesis that while the NRF2-KEAP1 inhibitory complex is reported the main pharmacological target for DMF's NRF dependent functions, no study to date has explored the effects of DMF on DJ-1's expression, and vice-versa, the possibility of a regulatory inadequacy in the upstream, oxidant-responsive DJ-1 activator of the NRF2 cascade.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dimethyl Fumarate; Multiple sclerosis; NRF2; PARK7/DJ-1

Mesh:

Substances:

Year:  2018        PMID: 29529529     DOI: 10.1016/j.msard.2018.02.027

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  4 in total

1.  The emerging epigenetics of PARK7 and its implication in neurodegenerative disease.

Authors:  George D Vavougios; Sotirios G Zarogiannis
Journal:  Neural Regen Res       Date:  2018-09       Impact factor: 5.135

Review 2.  Critical Involvement of Glial Cells in Manganese Neurotoxicity.

Authors:  Jazmín Soto-Verdugo; Arturo Ortega
Journal:  Biomed Res Int       Date:  2021-10-06       Impact factor: 3.411

Review 3.  Recent Advances in Understanding Nrf2 Agonism and Its Potential Clinical Application to Metabolic and Inflammatory Diseases.

Authors:  Min-Ji Kim; Jae-Han Jeon
Journal:  Int J Mol Sci       Date:  2022-03-05       Impact factor: 5.923

Review 4.  Research Progress on Targeted Antioxidant Therapy and Vitiligo.

Authors:  Jingzhan Zhang; Wen Hu; Peng Wang; Yuan Ding; Hongjuan Wang; Xiaojing Kang
Journal:  Oxid Med Cell Longev       Date:  2022-03-14       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.